Insights

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Products are incorporating increasingly complex technology, putting greater pressure on the supply chain. As a result, gaps are forming and the risk to reputations and revenues is growing through issues such as...

Surgical robotics will have a prosperous short-term future, with most key players expected to introduce laparoscopic surgical robotic systems by 2020. By 2030, the convergence of several technology opportunities, including...

In this talk, we explore some of the challenges and opportunities inherent to the adoption of remote monitoring, AI and wearables. We draw on our experience to demonstrate how the digital transformation of trials is possible with a collaborative approach between engineering, healthcare bodies and the pharmaceutical industry.

An aging population suffering from ever-more complex chronic conditions and concerns about health funding catching up, let alone keeping pace. If that’s the gloomy global state of healthcare in short-form, then many are pinning their hopes on home care – buoyed by the promise of remote patient monitoring – to provide the remedy.

With patients spending less time in hospital and more time at home or in long-term care establishments, the future is bright for medical bed manufacturers able to deliver the innovative solutions that are needed to successfully reshape healthcare delivery.

Consumer healthcare device or regulated medical device? The distinction is becoming more complex, fortunately there is FDA guidance on how to navigate these pathways

Cambridge Consultants recently brought together some of the brightest names and biggest companies in the medical device industry, to explore how surgical navigation can democratize surgery in the future and to envision the surgical navigation ecosystem of 2030.

The recent launch of the Apple Watch Series 4 is the latest example of a device developed by a traditional consumer product company making a well-publicized entry into the patient-facing medical device market. Patient-facing devices...

Apple just released the software to enable taking a home ECG on the Watch 4. I tried it out! Will this impact our health?

The rising cost of clinical trials (CTs), coupled with the commercial risks of failure, mean it’s increasingly important to harness the power of real-world data to inform effective trial designs, better understand outcomes and maximise the likelihood of clinical success...